Skip to main content
Equibles
PRVA logo

PRVA · Privia Health Group, Inc. · Metrics

Track PRVA — free

Use PRVA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRVA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$24.80 +0.38 (+1.54%) Play latest call Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.12B
Shares
127.77M
Volume · Nov 9 281.29K Avg daily vol (3M) 1.27M

PRVA metrics

97 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$24.42
Market cap
$3.12B

Price action

23 metrics
Price change (1W)
+13.7%
Price change (30D)
+17.1%
Price change (3M)
+8.8%
Price change (6M)
+5.9%
Price change (YTD)
+3.0%
Price change (1Y)
+1.8%
Trailing year
Price change (5Y)
-11.1%
52-week high
$28.10
52-week low
$19.10
Change from 52-week high
-13.1%
Change from 52-week low
+27.9%
Annualized volatility
32.7%
Annualized volatility (3M)
28.0%
Implied volatility (30D)
73.1%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.4
RSI (14D)
72.6
Price vs SMA 50
+16.0%
Price vs SMA 200
+7.8%
Avg volume (3M)
1.27M
Relative volume
2.2
Average dollar volume
$27.09M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
127.77M

Valuation

12 metrics
P / E (TTM)
90.4
Trailing earnings · reciprocal yield 1.1%
PEG ratio
0.9
EV / revenue
1.1×
reciprocal yield 91.1%
EV / EBITDA
41.9×
reciprocal yield 2.4%
EV / EBIT
52.4×
reciprocal yield 1.9%
P / sales
1.3×
reciprocal yield 78.0%
P / book
3.8
reciprocal yield 26.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
28.9
reciprocal yield 3.5%
Earnings yield
1.0%

Historical valuation

8 metrics
P / E historical average (3Y)
157.2×
reciprocal yield 0.6%
P / E historical average (5Y)
149.3×
reciprocal yield 0.7%
EV / revenue historical average (3Y)
1.2×
reciprocal yield 82.9%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 65.7%
EV / EBIT historical average (3Y)
105.3×
reciprocal yield 0.9%
EV / EBIT historical average (5Y)
115.9×
reciprocal yield 0.9%
EV / EBITDA historical average (3Y)
75.1×
reciprocal yield 1.3%
EV / EBITDA historical average (5Y)
125.7×
reciprocal yield 0.8%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-05

Profitability

9 metrics
Gross margin
—
Operating margin
2.1%
Trailing 12 months
Net margin
1.3%
Gross profit (TTM)
—
Operating profit (TTM)
$51.01M
Net income (TTM)
$32.32M
Trailing 12 months
Diluted EPS (TTM)
$0.27
FCF margin
—
Effective tax rate
37.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$18.51
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$0.39
EBITDA per diluted share (TTM)
$0.48
Net income per diluted share (TTM)
$0.25
Operating cash flow per diluted share (TTM)
$0.83
Free cash flow per diluted share (TTM)
$0.65
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.54
Book value per share
$5.96

Growth

11 metrics
Revenue growth YoY
+13.2%
Year over year
Net income growth YoY
+96.6%
Revenue (TTM)
$2.43B
Trailing 12 months
EPS growth YoY
+100.0%
Shares change YoY
+3.1%
Year over year · more shares
Revenue CAGR (3Y)
+16.1%
Revenue CAGR (5Y)
+21.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-11.4%
FCF CAGR (3Y)
+28.0%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
4.0%
Return on assets
2.1%
Debt / equity
0.0
Current ratio
1.6
EBITDA (TTM)
$63.81M
Free cash flow (TTM)
—
Quick ratio
1.6
Interest coverage
—
Net debt / EBITDA
-7.0
Return on invested capital
8.6%
Trailing 12 months
Net cash
$446.28M
Latest balance sheet
Cash & equivalents
$446.28M
Total assets
$1.56B
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$108.07M
Capital expenditures (TTM)
$113,000
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$70.80M
R&D / revenue
—
Stock compensation / revenue
2.9%

Ownership (13F)

9 metrics
13F filers
303
13F filer change QoQ
+10
Institutional ownership
96.8%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
17.9%
Private-fund adviser ownership
17.4%
Active holders' share change QoQ
-1.5%
Holder tenure
12.7
Price vs estimated holder cost
+3.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
26.0%

Short interest

3 metrics
Short interest
3.9%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1759655 CUSIP 74276R102 13F (30d) 131 filings 118 filers Visit website Investor relations